IMMUNOTHERAPY WITH B CELL ACTIVATING ANTIBODY CPI-006 IN PATIENTS (PTS) WITH MILD TO MODERATE COVID-19 STIMULATES ANTI-SARS-COV-2 ANTIBODY RESPONSE, MEMORY B CELLS AND MEMORY T EFFECTOR CELLS
Journal for Immunotherapy of Cancer
; 8:A199-A200, 2020.
Article
in English
| Web of Science | ID: covidwho-1105513
Full text:
Available
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Experimental Studies
Language:
English
Journal:
Journal for Immunotherapy of Cancer
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS